A5059283068- Pulmonary Hypertension Research and Treatments
- Congenital Heart Disease Studies
- Cardiovascular Issues in Pregnancy
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Vascular Anomalies and Treatments
- Healthcare Systems and Public Health
- Cardiac Imaging and Diagnostics
- Cardiovascular and Diving-Related Complications
- Ultrasound in Clinical Applications
- Heart Rate Variability and Autonomic Control
- Cardiovascular Disease and Adiposity
- Atrial Fibrillation Management and Outcomes
- Mechanical Circulatory Support Devices
- Vascular anomalies and interventions
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- Hemodynamic Monitoring and Therapy
- Transplantation: Methods and Outcomes
- Obstructive Sleep Apnea Research
- Cardiovascular and exercise physiology
- Venous Thromboembolism Diagnosis and Management
- Neuroscience of respiration and sleep
- Cardiac, Anesthesia and Surgical Outcomes
National Medical Research Center of Cardiology
2025
Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences
2017-2024
Russian Medical Academy of Continuous Professional Education
2018-2022
Ministry of Health of the Russian Federation
2018-2020
.
.
Russian Society of Cardiology (RSC) With the participation: Association Cardiovascular Surgeons Russia, Respiratory Society, Federation Anesthesiologists and Resuscitators, Rheumatologists National Congress Radiation Diagnosticians.
The Russian Society of Cardiology (RSC) With the participation of: Association Cardiovascular Surgeons, Eurasian (EAC), Medical on Arterial Hypertension (RMSAH), Respiratory (RRS), Anesthesiologists and Intensive Care Specialists, Radiologists (RSRR), Rheumatologists Russia. Endorsed by Research Practical Council Ministry Health Federation (12.09.2024).
Disclaimer The EAC Guidelines represent the views of EAC, and were produced after careful consideration scientific medical knowledge, evidence available at time their publication. is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies. Health professionals are encouraged take fully into account when...
Relevance. Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare severe form of due to artery obstruction. According number previously published studies, sleep-disordered breathing (SDB) was frequently observed in patients with CTEPH. However, despite the high incidence both general population and this group patients, aggravating effect SDB on clinical picture CTEPH has not been sufficiently studied. Aim: analyze occurrence various breathing, as well study aspects relationships...
Since 2004, different techniques for the Potts shunt have been used in patients with incurable pulmonary arterial hypertension. However, experience these interventions a single institution is limited. We present our series of shunts children hypertension.Eight suprasystemic hypertension (pulmonary artery-to-aorta mean pressure ratio 1.39 ± 0.30) had at median age 13.5 months. Six were followed up 2-32 (median 17) months after operation.In all cases, caused decrease blood oxygen saturation...
The aim of this study was to analyze results stenting atrioseptostomy in patients with pulmonary arterial hypertension and a different level risk for one-year mortality that is not well described. Patients underwent were retrospectively divided two groups: "intermediate" (
Настоящие российские рекомендации по легочной артериальной гипертензии, ассоциированной с врожденными пороками сердца у взрослых, разработаны на основании опубликованных международных рекомендаций и более чем 50-летнего опыта лечения больных гипертензией в НЦССХ им. А.Н. Бакулева. Представлены современная классификация гипертензии при врожденных пороках сердца, алгоритмы ее диагностики (в том числе тест вазореактивность), хирургического медикаментозного лечения. Отдельно рассмотрена легочная...
Pulmonary hypertension (PH) is a severe and often rapidly progressive disease with fatal outcome. Endothelial dysfunction in PH associated decreased nitric oxide production. After reviewing the mechanisms of action evidence base for specific therapy phosphodiesterase 5 inhibitors (PDE-5) soluble guanylate cyclase stimulators, reseach review on switching from PDE-5 to riociguat conducted. A potential advantage its independence endogenous other (besides PDE-5) isoenzymes phosphodiesterases....
Pulmonary hypertension (PH) in pediatrics is a polygenic multifactorial condition with extremely adverse prognosis. Selection of optimal management severe task. In absence treatment the mean life duration children not higher one year. Last two decades, revolution approaches to improved survival this patients group. Recently, pediatricians and pediatric cardiologists have three drugs groups that act on main pathogenetic chains PH: endothelin pathway, nitric oxide pathway prostacyclin pathway....
Обзор посвящен современной доказательной базе специфических легочных вазодилататоров при лечении недостаточности кровообращения у больных после операции Фонтена. Подробно рассмотрена патологическая физиология циркуляции по принципу Эффективность илопроста Фонтена на сегодняшний день показана в одном исследовании, силденафила – нескольких рандомизированных и нерандомизированных исследованиях, бозентана а также метаанализе. Бозентан является единственным специфическим легочным вазодилататором,...
The calculated systolic, diastolic and mean pulmonary artery pressure, the ratio of sizes right left ventricles heart, eccentricity index ventricle, systolic excursion fibrous ring tricuspid valve, movement myocardium at level valve area atrium are main echocardiographic indicators for assessing idiopathic similar forms hypertension according to current Russian, Eurasian European guidelines in children adults, as well recommendations 6th World Symposium on Pulmonary Hypertension. article...
Введение. Идиопатическая легочная артериальная гипертензия (ЛАГ) – тяжелое и часто быстро прогрессирующее заболевание с фатальным исходом. Атриосептостомия (АСС) позволяет улучшить клиническое состояние больных за счет декомпрессии правых отделов сердца, увеличения преднагрузки левого желудочка, сердечного выброса и, несмотря на умеренную гипоксемию, улучшения доставки к тканям кислорода.
After reviewing the current definitions and classification of pulmonary hypertension (PH) associated with congenital heart disease (CHD), based on an analysis 59 clinical trials (of which 14 are randomized controlled trials) drugs registered in Russian Federation, evidence base for PH therapy adults CHD is provided. The presence a trial bosentan BREATHE-5 uncontrolled other became basis higher class level (IB) compared to (IIaC) Eisenmenger syndrome European (ERS/ESC 2015) updated (2020)...
The outcome of treatment adult patients with congenital heart disease (CHD) and pulmonary hypertension (PH) depends on the adequacy diagnosis a thorough assessment hemodynamics correctness chosen tactics. Enormous success has been achieved, various classifications algorithms for managing children adults this nosology have created are widely used. Thanks to creation widespread introduction into clinical practice types drugs, results surgical CHD PH improved significantly. A new cluster...
Association of Cardiovascular Surgeons Russia Russian Society Cardiology (RSC) Pediatric Cardiologists Scientific Specialists in X-Ray Endovascular Diagnostics and Treatment All-Russian Public Organization for the Promotion Radiation Therapy "Russian Radiologists Radiologists". Task Force members declared no financial support/conflicts interest. If conflicts interest were reported, member(s) working group was (were) excluded from discussion sections related to area conflict
Eisenmenger syndrome (ES) is systemic pulmonary hypertension with venoarterial or bidirectional shunting of blood between the ventricles, atria great arteries due to progression vascular disease in natural course “simple” and “complex” congenital heart defects.Patients ES require constant attention from a multidisciplinary team specialists. One main tasks not destabilize fragile pathological physiology, which relies on balance peripheral resistance. Surgical interventions anesthesia, if they...